{"id":"W4289912960","doi":"10.1007/s40744-022-00474-5","title":"Long-Term Efficacy and Safety of Risankizumab in Patients with Active Psoriatic Arthritis: Results from a 76-Week Phase 2 Randomized Trial","year":2022,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"AbbVie; Boehringer Ingelheim","keywords":"Medicine; Placebo; Internal medicine; Rheumatology; Psoriatic arthritis; Randomized controlled trial; Adverse effect; Clinical endpoint; Psoriasis Area and Severity Index; Psoriasis; Gastroenterology; Arthritis; Physical therapy; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003872897,0.001124023,0.002149541,0.0002451901,0.0003935906,0.0008744181,0.0006502272,0.001218128,0.004974994],"category_scores_gemma":[0.001871584,0.000479844,0.001987083,0.0002981071,0.0007352483,0.0008684116,0.000385425,0.002142966,0.0008918021],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006019667,"about_ca_system_score_gemma":0.001053944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003300042,"about_ca_topic_score_gemma":0.0009370989,"domain_scores_codex":[0.9987347,0.0006987147,0.0001189626,0.000184175,0.0001481333,0.0001154253],"domain_scores_gemma":[0.9983751,0.0004058249,0.0005412023,0.0001414529,0.00009607652,0.0004403898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.958914,0.007505177,0.001859028,0.0007916591,0.001547706,0.00005285464,0.0000635083,0.0004317214,0.003875578,0.00005669085,0.000661631,0.02424043],"study_design_scores_gemma":[0.9070104,0.08518615,0.005339923,0.0000479913,0.0007327991,0.00005848446,0.00001549167,0.0002399638,0.0006064554,0.00007233558,0.0006703013,0.00001967104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882519,0.006516434,0.0005093686,0.0004661059,0.0002056514,0.00182828,0.0008780681,0.00006545576,0.001278755],"genre_scores_gemma":[0.9863411,0.0040065,0.001873931,0.0008375641,0.0004164675,0.002986457,0.001245623,0.0000174972,0.002274893],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004974994,"threshold_uncertainty_score":0.02048212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01031434900425969,"score_gpt":0.2628086861174515,"score_spread":0.2524943371131918,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}